Kangji Medical is a medical device group founded in 2004 with headquarters at Hangzhou, Zhejiang Province, China. We were listed at the mainboard of the Stock Exchange of Hong Kong in June 2020 (Stock Code: 9997.HK). We specialize in the design, development, manufacture and sale of minimally invasive surgery instruments and accessories (“MISIA”) . We strive for the mission of “providing physicians with high-quality products and services, and dedicating to improve people’s health”. We offer a comprehensive product portfolio to provide physicians and hospitals one-stop and tailored surgical solutions primarily for four major surgical specialties, including obstetrics and gynecology, general surgery, urology, and thoracic surgery. And we are committed to developing an internationally recognized minimally invasive surgery instruments and accessories platform with global coverage.
We have established research platforms, including Provincial Academician Research Workstation, Provincial Enterprise Research Institute and Enterprise High and New Technology Research Centre, to facilitate the development of MISIA products that meet the clinical needs. Our comprehensive and solution-oriented product portfolio can improve surgical efficiency and clinical outcomes for patients. We have received international accreditations for our quality control program, including EN ISO 13485:2016, ISO 9001:2015, ISO 45001:2018, ISO 14001:2015 and CE(93/42/EEC).
In domestic market, our high product quality, comprehensive product portfolio, effective academic promotion and extensive network of distributors, and competitive pricing have helped us gain over 70% penetration in Grade IIIA hospitals in China with minimally invasive surgery capabilities. Going global, we currently export our major products to Europe, South America and other Asian countries and regions. Leveraging our overseas regulatory and sales experience, we will continue to exploit overseas market potential by expanding our overseas business team to formulate and execute our business development strategy, establishing overseas offices and seeking collaboration opportunities with local sales channels.
test
